Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia
Kate E Mackin, Briony Elliott, Despina Kotsanas, Benjamin P Howden, Glen P Carter, Tony M Korman, Thomas V Riley, Julian I Rood, Grant A Jenkin, Dena Lyras
ANAEROBE | ELSEVIER SCI LTD | Published : 2015
Some Australian strain types of Clostridium difficile appear unique, highlighting the global diversity of this bacterium. We examined recent and historic local isolates, finding predominantly toxinotype 0 strains, but also toxinotypes V and VIII. All isolates tested were susceptible to vancomycin and metronidazole, while moxifloxacin resistance was only detected in recent strains.
Related Projects (1)
Awarded by Australian National Health and Medical Research Council (NHMRC)
Awarded by Australian Research Council (ARC)
Awarded by ARC Future Fellowship
Awarded by NHMRC Career Development Fellowship
The researchers were supported by Project Grant GNT1051584 from the Australian National Health and Medical Research Council (NHMRC) and Discovery Grant DP1093891 from the Australian Research Council (ARC). DL was supported by an ARC Future Fellowship (FT120100779) from the ARC. BH was supported by an NHMRC Career Development Fellowship (GNT1023526).